Evidence map›Paper›PMID 39795108›Full record

ReviewMolecules (Basel, Switzerland)2024

Weakly-Activated Phenol Derivatives as New Green Electrophilic Partners in Suzuki-Miyaura and Related C-C Couplings.

Jules Perney, Alexandre Humblot-Negri, Carlos Vaca-Garcia, Sébastien Lemouzy, Martine Urrutigoïty

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jules PerneyLaboratoire de Chimie Agro-Industrielle, INRAE, Toulouse-INP, Université de Toulouse, 31030 Toulouse, France.
Alexandre Humblot-NegriLaboratoire de Chimie Agro-Industrielle, INRAE, Toulouse-INP, Université de Toulouse, 31030 Toulouse, France.
Carlos Vaca-GarciaLaboratoire de Chimie Agro-Industrielle, INRAE, Toulouse-INP, Université de Toulouse, 31030 Toulouse, France.ORCID 0000-0001-9078-5179
Sébastien LemouzyLaboratoire de Chimie Agro-Industrielle, INRAE, Toulouse-INP, Université de Toulouse, 31030 Toulouse, France.
Martine UrrutigoïtyLaboratoire de Chimie de Coordination, CNRS, Toulouse-INP, Université de Toulouse, 31000 Toulouse, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, there has been growing interest in the development of greener alternatives to traditional reagents used in carbon-carbon coupling reactions, particularly in response to environmental concerns. The commonly used aryl halides, despite being highly reactive in the Suzuki-Miyaura coupling (SMC), pose significant environmental risks. As a result, research has shifted towards exploring the use of phenols, which are widely accessible and environmentally benign. However, phenols are considerably less reactive due to the poor leaving group properties of the hydroxyl group, necessitating prior activation to facilitate their use in coupling reactions. This work aims to review the recent investigations on the activation strategies for phenols, focusing on their application in the Suzuki-Miyaura and related C-C couplings. In addition, the exploration of the potential of conducting the activation step "in situ" will also be discussed. We hope that this article will pave the way for the development of more sustainable and efficient coupling methodologies, addressing both ecological and practical challenges in organic synthesis.

Indexed as

cross couplinggreen chemistryhomogeneous catalysisphenol derivativesSuzuki–Miyaura coupling

Identifiers

PMID39795108
PMCPMC11721199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.